Spots Global Cancer Trial Database for torisel
Every month we try and update this database with for torisel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients | NCT00877773 | Advanced Cancer... | Temsirolimus | - | M.D. Anderson Cancer Center | |
| Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients | NCT00877773 | Advanced Cancer... | Temsirolimus | - | M.D. Anderson Cancer Center | |
| Study of Temsirolimus, Topotecan, and Bortezomib | NCT00770731 | Advanced Cancer | Torisel (Temsir... Hycamtin (Topot... Velcade (Bortez... | - | M.D. Anderson Cancer Center | |
| Doxil, Bevacizumab and Temsirolimus Trial | NCT00761644 | Advanced Cancer | Doxil Bevacizumab Temsirolimus | 12 Years - | M.D. Anderson Cancer Center | |
| Doxil, Bevacizumab and Temsirolimus Trial | NCT00761644 | Advanced Cancer | Doxil Bevacizumab Temsirolimus | 12 Years - | M.D. Anderson Cancer Center | |
| STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma | NCT01653067 | Diffuse Large B... | Rituximab, Tems... | 18 Years - | University Hospital Heidelberg | |
| Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors | NCT00106353 | Adenocarcinoma Neoplasms | Torisel | 1 Year - 21 Years | Pfizer | |
| Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer | NCT01087554 | Advanced Cancer | Sirolimus Vorinostat Everolimus Temsirolimus | - | M.D. Anderson Cancer Center | |
| Hepatocellular Carcinoma (HCC)_Torisel_ | NCT01251458 | Inoperable HCC | Torisel | 18 Years - | Chinese University of Hong Kong | |
| Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma | NCT01687673 | Hepatocellular ... | Temsirolimus Sorafenib: | 18 Years - 85 Years | University of California, San Francisco | |
| Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer | NCT01087554 | Advanced Cancer | Sirolimus Vorinostat Everolimus Temsirolimus | - | M.D. Anderson Cancer Center | |
| Temsirolimus in Combination With Metformin in Patients With Advanced Cancers | NCT01529593 | Advanced Cancer... | Temsirolimus Metformin | 14 Years - | M.D. Anderson Cancer Center | |
| Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) | NCT01210482 | Renal Cell Carc... | Temsirolimus | - 99 Years | Pfizer | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus | NCT02093598 | Carcinoma, Endo... mTOR Protein | Temsirolimus | 18 Years - | MedSIR | |
| Bevacizumab and Temsirolimus in Patients With Advanced Malignancy | NCT00610493 | Advanced Cancer | Bevacizumab Temsirolimus Additional Bloo... Biopsy DCE-MRI Scan | - | M.D. Anderson Cancer Center | |
| Temsirolimus In Phase 0 | NCT01417065 | Advanced Cancer | Temsirolimus | 18 Years - | M.D. Anderson Cancer Center | |
| Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) | NCT01122615 | Renal Cell Canc... Kidney Cancer | Sunitinib Temsirolimus | 18 Years - | M.D. Anderson Cancer Center | |
| Bevacizumab and Temsirolimus in Patients With Advanced Malignancy | NCT00610493 | Advanced Cancer | Bevacizumab Temsirolimus Additional Bloo... Biopsy DCE-MRI Scan | - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
